Zomedica Corp. (ZOMDF)
0.095
0.00 (0.00%)
USD |
OTCM |
Jun 08, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 93.10M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 113.5% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 2.712 |
| Price to Book Value | 0.8391 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.0181 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 98.88% |
Profile
| Zomedica Corp. engages in the discovery, development, and commercialization of pharmaceuticals for companion animals, including dogs, cats, and horses. The firm offers products focusing on the unmet needs of clinical veterinarians. It operates through the following segments: Diagnostics, Therapeutic Devices, and Development Services. The Diagnostics segment offers TRUFORMA, VETGuardian and TRUVIEW products. The Therapeutic Devices segment consists of Assisi, PulseVet and VETIGEL products. The Development Services segment includes contract manufacturing and engineering services. The company was founded by Gerald L. Solensky on January 7, 2013 and is headquartered in Ann Arbor, MI. |
| URL | http://www.zomedica.com |
| Investor Relations URL | N/A |
| HQ State/Province | Michigan |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Next Earnings Release | Aug. 06, 2026 (est.) |
| Last Earnings Release | May. 06, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Zomedica Corp. engages in the discovery, development, and commercialization of pharmaceuticals for companion animals, including dogs, cats, and horses. The firm offers products focusing on the unmet needs of clinical veterinarians. It operates through the following segments: Diagnostics, Therapeutic Devices, and Development Services. The Diagnostics segment offers TRUFORMA, VETGuardian and TRUVIEW products. The Therapeutic Devices segment consists of Assisi, PulseVet and VETIGEL products. The Development Services segment includes contract manufacturing and engineering services. The company was founded by Gerald L. Solensky on January 7, 2013 and is headquartered in Ann Arbor, MI. |
| URL | http://www.zomedica.com |
| Investor Relations URL | N/A |
| HQ State/Province | Michigan |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Next Earnings Release | Aug. 06, 2026 (est.) |
| Last Earnings Release | May. 06, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |